UIPATH INC - CLASS A (PATH) Fundamental Analysis & Valuation

NYSE:PATH • US90364P1057

Current stock price

10.67 USD
+0.37 (+3.59%)
At close:
10.6899 USD
+0.02 (+0.19%)
After Hours:

This PATH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PATH Profitability Analysis

1.1 Basic Checks

  • In the past year PATH was profitable.
  • PATH had a positive operating cash flow in the past year.
  • In the past 5 years PATH reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: PATH reported negative operating cash flow in multiple years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2026 0 200M -200M -400M

1.2 Ratios

  • With an excellent Return On Assets value of 8.88%, PATH belongs to the best of the industry, outperforming 83.46% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 13.56%, PATH is in the better half of the industry, outperforming 77.94% of the companies in the same industry.
  • The Return On Invested Capital of PATH (2.13%) is better than 65.81% of its industry peers.
Industry RankSector Rank
ROA 8.88%
ROE 13.56%
ROIC 2.13%
ROA(3y)1.09%
ROA(5y)-5.83%
ROE(3y)1.7%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2026 0 -50 -100 -150 -200 -250

1.3 Margins

  • With an excellent Profit Margin value of 17.53%, PATH belongs to the best of the industry, outperforming 83.09% of the companies in the same industry.
  • PATH has a Operating Margin of 3.80%. This is in the better half of the industry: PATH outperforms 65.81% of its industry peers.
  • The Gross Margin of PATH (83.21%) is better than 88.60% of its industry peers.
  • PATH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.8%
PM (TTM) 17.53%
GM 83.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-1.37%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PATH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PATH is destroying value.
  • The number of shares outstanding for PATH has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PATH has more shares outstanding
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B

2.2 Solvency

  • PATH has an Altman-Z score of 3.28. This indicates that PATH is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PATH (3.28) is better than 66.91% of its industry peers.
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.28
ROIC/WACC0.19
WACC10.94%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B

2.3 Liquidity

  • PATH has a Current Ratio of 2.48. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
  • PATH has a Current ratio of 2.48. This is in the better half of the industry: PATH outperforms 66.91% of its industry peers.
  • PATH has a Quick Ratio of 2.48. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
  • PATH's Quick ratio of 2.48 is fine compared to the rest of the industry. PATH outperforms 67.65% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.48
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PATH Growth Analysis

3.1 Past

  • PATH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
  • The Earnings Per Share has been growing by 68.69% on average over the past years. This is a very strong growth
  • Looking at the last year, PATH shows a quite strong growth in Revenue. The Revenue has grown by 12.65% in the last year.
  • Measured over the past years, PATH shows a very strong growth in Revenue. The Revenue has been growing by 21.53% on average per year.
EPS 1Y (TTM)33.33%
EPS 3Y68.69%
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)12.65%
Revenue growth 3Y15.01%
Revenue growth 5Y21.53%
Sales Q2Q%13.56%

3.2 Future

  • PATH is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.64% yearly.
  • Based on estimates for the next years, PATH will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y14.23%
EPS Next 2Y13.15%
EPS Next 3Y12.57%
EPS Next 5Y-1.64%
Revenue Next Year10.83%
Revenue Next 2Y9.66%
Revenue Next 3Y8.82%
Revenue Next 5Y10.52%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. PATH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.82, the valuation of PATH can be described as correct.
  • PATH's Price/Earnings ratio is rather cheap when compared to the industry. PATH is cheaper than 80.15% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.64, PATH is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 12.97, PATH is valued correctly.
  • Based on the Price/Forward Earnings ratio, PATH is valued a bit cheaper than 79.41% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. PATH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.82
Fwd PE 12.97
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PATH's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 79.78% of the companies in the same industry are more expensive than PATH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.87
EV/EBITDA 42.52
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as PATH's earnings are expected to grow with 12.57% in the coming years.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y13.15%
EPS Next 3Y12.57%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PATH Dividend Analysis

5.1 Amount

  • PATH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PATH Fundamentals: All Metrics, Ratios and Statistics

UIPATH INC - CLASS A

NYSE:PATH (5/1/2026, 8:04:00 PM)

After market: 10.6899 +0.02 (+0.19%)

10.67

+0.37 (+3.59%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry Strength6.83
Industry Growth86.34
Earnings (Last)03-11
Earnings (Next)05-27
Inst Owners80.26%
Inst Owner Change-0.13%
Ins Owners9.37%
Ins Owner Change-1.05%
Market Cap5.59B
Revenue(TTM)1.61B
Net Income(TTM)282.33M
Analysts67.86
Price Target14.06 (31.77%)
Short Float %26.17%
Short Ratio3.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.46%
Min EPS beat(2)7.4%
Max EPS beat(2)15.53%
EPS beat(4)4
Avg EPS beat(4)28.49%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)27.32%
EPS beat(12)12
Avg EPS beat(12)71.21%
EPS beat(16)16
Avg EPS beat(16)86.55%
Revenue beat(2)2
Avg Revenue beat(2)2.06%
Min Revenue beat(2)1.55%
Max Revenue beat(2)2.57%
Revenue beat(4)4
Avg Revenue beat(4)2.81%
Min Revenue beat(4)1.55%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.21%
Revenue beat(12)9
Avg Revenue beat(12)1.58%
Revenue beat(16)13
Avg Revenue beat(16)2.55%
PT rev (1m)-14.73%
PT rev (3m)-16.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.71%
EPS NY rev (1m)5.75%
EPS NY rev (3m)6.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.09%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.24%
Valuation
Industry RankSector Rank
PE 14.82
Fwd PE 12.97
P/S 3.47
P/FCF 15.87
P/OCF 15.06
P/B 2.68
P/tB 2.89
EV/EBITDA 42.52
EPS(TTM)0.72
EY6.75%
EPS(NY)0.82
Fwd EY7.71%
FCF(TTM)0.67
FCFY6.3%
OCF(TTM)0.71
OCFY6.64%
SpS3.07
BVpS3.98
TBVpS3.7
PEG (NY)1.04
PEG (5Y)N/A
Graham Number8.02466 (-24.79%)
Profitability
Industry RankSector Rank
ROA 8.88%
ROE 13.56%
ROCE 2.69%
ROIC 2.13%
ROICexc 6.03%
ROICexgc 7.37%
OM 3.8%
PM (TTM) 17.53%
GM 83.21%
FCFM 21.87%
ROA(3y)1.09%
ROA(5y)-5.83%
ROE(3y)1.7%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-1.37%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 112.25%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 475.08%
Profit Quality 124.73%
Current Ratio 2.48
Quick Ratio 2.48
Altman-Z 3.28
F-Score8
WACC10.94%
ROIC/WACC0.19
Cap/Depr(3y)77.11%
Cap/Depr(5y)89.47%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3Y68.69%
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y14.23%
EPS Next 2Y13.15%
EPS Next 3Y12.57%
EPS Next 5Y-1.64%
Revenue 1Y (TTM)12.65%
Revenue growth 3Y15.01%
Revenue growth 5Y21.53%
Sales Q2Q%13.56%
Revenue Next Year10.83%
Revenue Next 2Y9.66%
Revenue Next 3Y8.82%
Revenue Next 5Y10.52%
EBIT growth 1Y144.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.76%
EBIT Next 3Y14.4%
EBIT Next 5Y12.97%
FCF growth 1Y15.22%
FCF growth 3YN/A
FCF growth 5Y68.42%
OCF growth 1Y15.8%
OCF growth 3YN/A
OCF growth 5Y66.31%

UIPATH INC - CLASS A / PATH Fundamental Analysis FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 6 / 10 to PATH.


What is the valuation status for PATH stock?

ChartMill assigns a valuation rating of 5 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


Can you provide the profitability details for UIPATH INC - CLASS A?

UIPATH INC - CLASS A (PATH) has a profitability rating of 5 / 10.


What is the valuation of UIPATH INC - CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for UIPATH INC - CLASS A (PATH) is 14.82 and the Price/Book (PB) ratio is 2.68.